Zevalin helps lymphoma patient in Idaho to recover

10/18/2010 | KIFI-TV (Idaho Falls)

John Wolfe, a patient with lymphoma mantle cell B, is the first one in Portneuf Medical Center and in the southeastern Idaho area to be treated with Zevalin, a drug that accurately zeroes in and tags cancer cells. Doctors at the medical center said months of treatment with the drug has allowed Wolfe to begin recovering. The center is thinking about using the drug to treat more patients.

View Full Article in:

KIFI-TV (Idaho Falls)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ